M. Marty

8.9k citations
128 papers · 6.3k · 1 hit paper · h-index 41

Impact in

  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
  • Biotechnology top 0.2%
    • Microbial Inactivation Methods

Papers in

    • Cancer Treatment and Pharmacology 47
    • Colorectal Cancer Treatments and Studies 18
    • HER2/EGFR in Cancer Research 13
    • Neutropenia and Cancer Infections 12
    • Breast Cancer Treatment Studies 29
    • Cancer Genomics and Diagnostics 11

M. Marty

124 papers receiving 6.0k citations

M. Marty's Hit Papers

Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study 2006 · 628 citations
6280+6+13Years since publication200400600

Peers

M. Marty
Comparison fields: 5 of 133
  • Oncology 3.5k
  • Biotechnology 1.1k
  • Cancer Research 1.4k
  • Dermatology 290
  • Pulmonary and Respiratory Medicine 1.0k
Replace Ronald C. DeConti with:
Ronald C. DeConti United States
Kenji Kawada Japan
Chikashi Ishioka Japan
Monica Mita United States
Luka Milas United States
Anish Thomas United States
Alain C. Mita United States
Nancy Hunter United States
Hal W. Hirte Canada
Tetsuro Kubota Japan
M. Marty relative to Ronald C. DeConti United States Ronald C. DeConti's profile →
Citations per field
00.5×3.4×
Ronald C. DeConti · 1×
Citations per year

Countries citing papers authored by M. Marty

Since Specialization
Citations

This map shows the geographic impact of M. Marty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Marty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Marty more than expected).

Fields of papers citing papers by M. Marty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Marty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Marty. The network helps show where M. Marty may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Marty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Marty Line = papers co-authored together M. Marty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
Hit paper breakdown →
2006628
2 2006432
3 1996331
4 1990295
5
The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.
1992239
6
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.
1993227
7
Breast-conserving surgery in the neoadjuvant setting.
1998223
8 2009189
9 2004188
10 2008154
11 2006147
12 2001136
13
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
1994134
14 2001133
15 2007132
16 1996129
17 2007127
18 1999111
19 201085
20 201281

About M. Marty

M. Marty is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 128 papers that have together received 6.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (47 papers), Breast Cancer Treatment Studies (29 papers), Colorectal Cancer Treatments and Studies (18 papers), HER2/EGFR in Cancer Research (13 papers), Neutropenia and Cancer Infections (12 papers), Cancer Genomics and Diagnostics (11 papers), Cancer therapeutics and mechanisms (8 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Oncology (3.5k citations), Biotechnology (1.1k citations), Cancer Research (1.4k citations), Dermatology (290 citations) and Pulmonary and Respiratory Medicine (1.0k citations). M. Marty has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Marc Espié, Jean Marc Extra, Fabien Calvo, Z Rudolf, Lluis M. Mir, Julie Gehl, Gregor Serša, Gerald C. O’Sullivan, Poul Geertsen and Chris Collins. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact